Literature DB >> 21367600

Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.

N Dekker1, L G M van Rossum, M Van Vugt-van Pinxteren, S H C van Stiphout, R P M G Hermens, W A G van Zelst-Stams, M G H van Oijen, R J F Laheij, J B M J Jansen, N Hoogerbrugge.   

Abstract

BACKGROUND: The Dutch Health Council recently recommended the introduction of a colorectal cancer (CRC) screening programme by faecal occult blood testing (FOBT) for individuals aged 55-75 at population risk of CRC. Individuals at an increased familial CRC risk (≥ 2 times population risk) should be identified at a younger age, so they and their relatives can receive earlier, more intensive surveillance instead of FOBT. AIMS: To determine the percentage of participants with a positive FOBT in a CRC screening programme with an increased familial CRC risk.
METHODS: In a population-based study, 10,569 individuals aged 50-75 received an FOBT. Individuals with a positive FOBT were invited for colonoscopy and familial risk assessment. Participants with an average familial CRC risk were compared to those with an increased risk. Increased familial CRC risk was defined as a cumulative lifetime risk of CRC of at least 10%.
RESULTS: Of 6001 participants, 430 had a positive FOBT, of whom 324 (63% males; mean age 63 years) completed colonoscopy and familial risk assessment. CRC (n=22) and/or advanced adenomas (n=122) were found in 133 participants. Familial CRC risk was increased in 6% of participants with a positive FOBT. No significant differences were found between participants with an average versus an increased familial CRC risk.
CONCLUSION: Six percent of participants with a positive FOBT had an increased familial CRC risk. Identifying at-risk participants enables them and their relatives to undergo regular colonoscopies. Adding familial risk assessment to FOBT screening may thus prevent a substantial number of CRCs.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21367600     DOI: 10.1016/j.ejca.2011.01.022

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  2 in total

1.  Colorectal Cancer Screening in the Non-Syndromic Familial Risk Population: Is It Time to Revise the Clinical Guidelines?

Authors:  Enrique Quintero; Antonio Z Gimeno-García
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

2.  Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study.

Authors:  Sanne J H van Erp; Laura W Leicher; Simone D Hennink; Zeinab Ghorbanoghli; Simone A C Breg; Hans Morreau; Maartje Nielsen; James C H Hardwick; Jan A Roukema; Alexandra M J Langers; Wouter H de Vos Tot Nederveen Cappel; Hans F A Vasen
Journal:  Scand J Gastroenterol       Date:  2016-06-16       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.